Clinical Trials Logo

Vaccine Response Impaired clinical trials

View clinical trials related to Vaccine Response Impaired.

Filter by:

NCT ID: NCT01446978 Active, not recruiting - Clinical trials for Vaccine Response Impaired

Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Start date: September 2011
Phase: Phase 2
Study type: Interventional

Hepatitis A vaccine is the most frequently used traveler's vaccine, yet data on its ability to induce protective immunity in immunosuppressed travelers are scarce. The investigators assess the hepatitis A virus (HAV) antibody response in patients with rheumatoid arthritis (RA) treated with Tumor Necrosis Factor (TNF) - inhibitors and/or methotrexate (Mtx). In a previous study, 2 doses were not considered effective and there is therefore need for a study with an additional dose

NCT ID: NCT01119703 Completed - Clinical trials for Vaccine Response Impaired

Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2)

Start date: July 2010
Phase: N/A
Study type: Observational

This study evaluated whether it is possible in healthy elderly participants to generate baseline biomarker-based prediction rules (PdR) for vaccine response (post baseline absolute serum antibody titer) using each of the protocol selected vaccines separately; and examined the rank correlation coefficients of pairs of post vaccination antibody titers within the same elderly individuals.